Tislelizumab Deemed an ‘Important Option’ for Relapsed/Refractory Classical Hodgkin Lymphoma
The median overall survival was not reached at 3 years.
Hodgkin Lymphoma
Post-Traumatic Stress Symptoms Seen in Pediatric Hodgkin Lymphoma Survivors
Researchers sought to investigate the associations between PTSS and the experiences of pediatric survivors of Hodgkin lymphoma treated in the AHOD0031 study.
Serious Long-Term Adverse Events Decreased in Pediatric Hodgkin Lymphoma
A deepened understanding of long-term effects can help clinicians to better determine upfront therapy and monitoring strategies for pediatric patients with Hodgkin lymphoma.
Brentuximab Vedotin Shows Efficacy for Pediatric Patients With Classical Hodgkin Lymphoma
Researchers sought to determine the safety and efficacy of brentuximab vedotin in pediatric patients with classical Hodgkin lymphoma.
Long-Term Survivors of Childhood Hodgkin Lymphoma at Increased Risk for Neurocognitive Impairment
A St Jude Children’s Research Hospital team investigated potential causes of neurocognitive impairments in survivors of childhood Hodgkin lymphoma survivors.
Does Type of Radiation Therapy in Hodgkin Lymphoma Treatment Affect Lung Toxicity?
Researchers examined data from patients who were treated for Hodgkin lymphoma between 2009 and 2013 who had received radiation therapy as part of their treatment.
Causes of Mortality in Adults Treated for Hodgkin Lymphoma
Adults treated for Hodgkin lymphoma have an increased risk of death from heart disease, interstitial lung disease, infections, and adverse effects of therapy.
What Does Radiation Do to Organs at Risk in Patients With Lymphoma?
Depending on the type and stage of lymphoma, physicians may choose to avoid having their patients undergo radiation therapy for fear of potential toxic effects in organs. How has modern radiation therapy evolved of late in terms of what it can do to organs at risk? A study published earlier this year in JAMA Network…
Conventional Chemotherapy May Be Effective in Early-Stage Hodgkin Lymphoma After Relapse
Among patients with early-stage, favorable Hodgkin lymphoma, treatment regimens with conventional chemotherapy may be effective in a subset of patients.
Modern Radiation Therapy Limits Radiation Doses to Organs at Risk in Hodgkin Lymphoma
Combined modality therapy for early-stage favorable HL yielded excellent outcomes and limited excess radiation doses to organs at risk.
- Loading...
Loading...
Loading... 
Loading...